Food & drink question
Coffee is one of the more interesting drinks in liver research, but it is not a treatment. In people with MASLD, coffee drinking has been associated with less liver damage and fewer liver-related clinical outcomes in observational studies. That means the evidence is encouraging, not proof that coffee itself caused the benefit.
General information, not personalised medical advice. If caffeine worsens palpitations, anxiety, reflux, sleep or another condition, or if your healthcare team has told you to restrict it, follow that individual advice.
The quick answer
The 2024 EASL–EASD–EASO clinical guideline for MASLD says that coffee consumption has been associated with improvements in liver damage and reduced liver-related clinical outcomes in observational studies. The guideline grades that statement as lower-level observational evidence rather than a treatment recommendation.
Mayo Clinic makes a similar distinction: some studies suggest black caffeinated coffee may be linked with a lower risk of MASLD and liver scarring, but the exact mechanism is uncertain. It also makes the practical point that a high-sugar coffee drink is a very different dietary choice from plain coffee.
Evidence in context
The evidence is interesting enough to discuss, but not strong enough to turn coffee into a prescription.
Observational studies have repeatedly linked coffee drinking with better liver-related measures, particularly fibrosis and broader chronic-liver-disease outcomes. The European guideline recognises this association, while stopping short of prescribing a dose.
Different studies define a cup differently and examine different populations. Some NHS liver-diet leaflets discuss one to three cups or around three cups per day, but that should not be read as a universal target for every person with MASLD.
Some observational work and NHS patient information note similar associations in decaffeinated coffee drinkers. That suggests caffeine may not be the whole story, but the evidence does not justify promising that decaf and caffeinated coffee have identical effects.
Coffee itself is not the same as a drink built around syrups, whipped cream or large amounts of sugar. For everyday use, unsweetened coffee or coffee with a modest amount of milk is easier to fit into the wider MASLD pattern than a dessert-style coffee drink.
Make the cup practical
There is no need to turn the preparation method into a complicated ranking system. UK NHS liver information has discussed filtered, instant and espresso coffee in the context of liver health, and some patient guidance also notes encouraging findings for decaf.
The simplest choice is the type you enjoy and tolerate, prepared without routinely turning it into a high-sugar drink. If you prefer decaf because of sleep, palpitations or caffeine sensitivity, there is no good reason to switch to caffeinated coffee solely because of a fatty-liver headline.
Caffeine & individual circumstances
The liver question is only one part of the decision. Caffeine can affect sleep and may not suit everybody. Bradford Teaching Hospitals notes that caffeine can remain active for hours and advises avoiding stimulants later in the day when sleep is a problem.
Individual advice matters if you have symptoms or conditions affected by caffeine, are pregnant, take medicines that interact with caffeine, or have been given a specific fluid or dietary plan. This page cannot turn population-level observations into a personal dose.
The Food Lookup gives quick context for coffee, tea, water, sugary drinks and 45+ other foods and drinks.
Common questions
If you already drink coffee and tolerate it, current evidence does not suggest you need to stop because of MASLD. But coffee is optional, and observational evidence is not a reason to force yourself to start.
Black coffee is the easiest way to avoid added sugar and extra saturated fat, but a modest amount of milk can also fit. The main concern is routinely turning coffee into a sugar-heavy drink.
Some studies and NHS patient information report encouraging findings with decaffeinated coffee too. The evidence is not strong enough to promise the same effect as caffeinated coffee, but choosing decaf for tolerance reasons is entirely reasonable.
There is no single universally proven MASLD dose. Some UK NHS information discusses around one to three or three cups per day, but the European guideline itself does not prescribe a coffee target. Personal caffeine tolerance still matters.
Evidence & sources
This page prioritises current clinical guidelines and hospital/NHS patient information. It deliberately describes coffee research as an association rather than proof of treatment.